Transplantation with wild-type bone marrow to Rgc32−/− mice does not alter the protective effects of Rgc32 deletion on atherosclerosis development, suggesting the critical roles of resident vascular cell RGC32 in the lesion development. This evidence concerns the gene RGCC and atherosclerosis.